How to Avoid Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Gastrointest Endosc Clin N Am. 2018 Oct;28(4):439-454. doi: 10.1016/j.giec.2018.05.007.

Abstract

Pancreatitis remains the most common and potentially devastating complication of endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Recent advances in prophylaxis have improved but not eliminated this problem, underscoring the importance of ongoing research toward this goal. This review aims to provide an evidence-based approach to post-ERCP pancreatitis prevention through patient selection, risk stratification, procedural technique, and multimodality prophylaxis, and discusses ongoing and future research initiatives in this important area.

Keywords: Complications; ERCP; Endoscopic retrograde cholangiopancreatography; Pancreatitis; Post-ERCP pancreatitis.

Publication types

  • Review

MeSH terms

  • Administration, Rectal
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
  • Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
  • Cholangiopancreatography, Endoscopic Retrograde / methods
  • Humans
  • Pancreatitis / etiology*
  • Pancreatitis / prevention & control*
  • Patient Selection
  • Ringer's Lactate / therapeutic use
  • Risk Assessment
  • Stents

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Ringer's Lactate